Plain-English translation of NCT06576583 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new surgical treatment called N-TEC (nasal chondrocyte-based tissue engineered cartilage) for people with osteoarthritis in the front part of the knee. N-TEC uses cells from your own nose that are grown in a lab and placed on a special collagen membrane to create new cartilage tissue, which is then surgically implanted into your damaged knee. The study will compare this treatment to standard surgical options to see which works best for reducing pain and improving knee function.
Cartilage damage in the front of the knee is a common cause of pain and disability affecting millions of people worldwide. Current surgical treatments have limited ability to regenerate damaged cartilage, so researchers are testing whether lab-grown cartilage tissue can better repair the damage and restore normal knee function.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive surgery to implant either the lab-grown cartilage graft or a standard surgical treatment, depending on the severity of your knee damage and which group you are randomly assigned to. You will have multiple follow-up visits over the study period where doctors will assess your knee pain and function using questionnaires, X-rays, and MRI scans. You will need to complete a structured rehabilitation program after surgery and commit to attending all study visits and assessments.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Austria
Croatia
Germany
Italy